Hirsutism by definition describes the quality of body hair, implying coarseness, but common usage has extended the meaning to denote an excess of hair-locally or generalised. Body hair is of two types: fine, non-pigmented vellus hair-for example, facial "down"-and coarser pigmented terminal hair as in the scalp and axillas. The visual impression of hairiness is produced by the coarser type. Hirsutism reflects the response of hair follicles to androgenic stimulation, and is therefore a symptom and a clinical sign but not a specific disease entity. Both genetic and hormonal factors affect hair growth, and in different parts of the world cultural factors determine what is socially acceptable in respect of quality, quantity, and distribution of body hair. Thus hirsutism that is quite acceptable in one community may cause severe embarrassment or even psychological disturbance to a woman in another. Yet around 30V0 of women between the ages of 15 and 44 normally have hair on the upper lip, 90' on the chin, and 60o on the sides of the face.'
The three most important androgens are androstenedione, testosterone, and dihydrotestosterone. Androstenedione is the least and dihydrotestosterone the most potent, but as androstenedione can be directly converted to dihydrotestosterone in the skin its potential androgenic importance may be considerable.' Secretion of both androstenedione and testosterone from the adrenals and ovaries increases in hirsute women. [3] [4] [5] There is also evidence in some hirsute women that increased conversion of androstenedione to dihydrotestosterone may occur locally in the skin2 but whether other androgens, such as dehydroepiandrosterone or androstenediol, influence the development of hirsutism is not known.
When testosterone production increases or the ratio of testosterone to oestrogen concentration is weighted in favour of the androgen, SHBG concentration falls.6 This is therefore a secondary phenomenon in patients with hirsutism, exacerbating the effect of increased androgen production. Another possible mechanism might be a primary decrease in SHBG production in some women with no rise in androgen secretion (E P Giorgi, J Ginsburg, E Padipaasian, unpublished observations). This might be a factor in some cases of drug-induced hirsutism, or in certain races. Corticosteroids (rarely) Hypothyroidism Acromegaly diagnosis by exclusion. The characteristic changes in sclerocystic ovaries (also known as the polycystic ovary syndrome) are multiple cysts and subcapsular fibrosis. The cysts can be shown by ultrasound, gynaecography, or laparoscopy, and the fibrosis by ovarian biopsy.
The ovarian changes are the common denominator of a heterogeneous group of conditions.7 Clinically, patients may present with infertility and amenorrhoea, but also with obesity and rarely with virilisation. Hirsutism is common though not invariable in women with sclerocystic ovaries, 8 and in our experience it may be the only clinical sign in this condition. Idiopathic hirsutism, as the table shows, may also be the common end result of several different pathological processes. Genetic factors, increasing the skin's sensitivity to androgens, may be concerned in both idiopathic hirsutism and sclerocystic ovaries.
Hirsutism is occasionally the presenting symptom in hypothyroidism and also in certain rare conditions such as Cushing's syndrome, congenital adrenal hyperplasia, and androgensecreting tumours of the adrenal or ovary. Congenital adrenal hyperplasia and androgen-secreting tumours are associated with signs of virilisation, and in Cushing's syndrome there is usually other evidence of adrenocortical overactivity. More rarely, hirsutism is the presenting complaint in women with acromegaly or anorexia nervosa.
Drug-induced hirsutism is being increasingly recognised; phenytoin, diazoxide, and minoxodil are recognised causes. Androgens, as a component of mixed treatment given at the menopause, are also sometimes responsible for hirsutism.
Biochemistry
It is not surprising, in view of the heterogeneity of the conditions in which hirsutism may occur, that biochemical investigation in hirsute women has produced conflicting results. There is no single, simple diagnostic test.
Plasma testosterone may be only slightly raised, and in many cases the circulating concentration is within the normal female range. Selective venous catheterisation of adrenal and ovarian veins, however, has shown increased androgen secretion from both sources in hirsute women.9 Hypersensitivity of adrenal androgen secretion in response to adrenocorticotrophic hormone has been shown in some cases'0 and mild degrees of adrenal 11-and 21-hydroxylase deficiencies in others.'0 " 1 An imbalance of gonadotrophin secretion may be related to increased ovarian androgen production in sclerocystic ovaries;"2 pharmacological doses of human chorionic gonadotrophin (HCG) release ovarian androgens but exert no effect on adrenal androgen secretion." On the other hand, there are case reports of androgen-secreting tumours of the adrenal sensitive to HCG.14 A degree of autonomous adrenal activity may occasionally be present in hirsute women; pulsatile adrenal androgen secretion has been observed despite suppressive prednisolone treatment.'4 Similarly, we showed appreciable adrenal venous androgen secretion after high-dose dexamethasone in one of our hirsute patients (M C White, J Ginsburg, unpublished observations).
Hyperprolactinaemia has been found in some hirsute patients with raised plasma testosterone concentrations, and after bromocriptine treatment plasma testosterone fell in parallel with the reduction in prolactin concentration. 
The plasma testosterone concentration is generally considerably raised in androgen-secreting tumours, but patients with a recent history of virilisation, in whom other causes have been excluded should be suspected of having a tumour whatever the concentration of testosterone. Adrenal tumours may be diagnosed by means of radio-labelled cholesterol scans, computed tomography, or ultrasound.'7 Selective venous catheterisation should be considered in the investigation of an ovarian tumour.'8 It is, however, technically difficult,'9 and may even be misleading if tumour secretion is pulsatile and only single samples are taken. An ovarian tumour may be missed at laparoscopy; laparotomy and cleavage of the ovaries may be needed to exclude an ovarian hilar-cell androgen-secreting tumour.
If the patient appears to have idiopathic hirsutism or the sclerocystic ovary syndrome plasma androgen measurements are of little value in management, and measurements of urinary 17- 
The drug has not, however, been passed by the Committee on Safety of Medicines for the routine treatment of hirsutism, and is available for this purpose only for named patients. It has to be given in a reverse sequential contraceptive regimen with ethinyloestradiol, since feminisation of a male fetus may occur after cyproterone acetate. There are also other side effects. Mild pituitary adrenal axis suppression has been reported in man,27 while in animals the drug has been associated with the development of hepatic tumours.28 Long-term effects of continued administration of cyproterone acetate in man are not known.
At present a combination of prednisolone and ethinyloestradiol together with a progestogen given cyclically for between six months and one year would seem reasonable for initial treatment. If this particular treatment is not helpful it should be discontinued. Until more is known about the action of cyproterone acetate, its use should be reserved for specialised centres.
In a small group of patients we have not found bromocriptine helpful. Indeed in one the hirsutism actually progressed while she was taking the drug. Yes. Thiazide diuretics decrease the excretion of uric acid from the distal tubule and lead to a rise in the uric acid level in the blood. This is of no practical importance except in those predisposed to gout. This effect of thiazides is not confined to the elderly. Other diuretics such as frusemide, ethacrynic acid, and acetazolamide have also been reported as causing lesser degrees of hyperuricaemia.' The leading article on surgical diathermy (29 September 1979) reminds us of the possible dangers associated with its use. Is the following another possible hazard ? I suspect that in coagulating the blood flowing through the vessels a clot forms on the surface end which might also extend inwards and become detached to enter the systemic circulation. Such clots ifformed in large quantities might cause post-traumatic respiratory insufficiency, especially after surgery necessitating large wounds.
Surgical diathermy is used to seal vessels in two distinct ways: the first is at open surgery to clamp the vessel with a pair of forceps and then apply the diathermy; the second is to touch the side of the bleeding vessel with a button electrode at endoscopic surgery. At open surgery, the walls of the vessel are in apposition under pressure within the forceps, this coagulates the walls of the vessel which then become adherent for a distance of 1 or 2 mm beyond the blades of the forceps. By using the diathermy button spasm of the vessel wall is induced by the high frequency current; the walls of the vessel then are in close apposition and readily seal when the vessel is coagulated. The process of haemostasis by diathermy could more accurately be described as sealing the vessel by coagulation rather than inducing a thrombus and occluding the vessel with blood clot. This being the case, thrombus could still develop proximal to the site of diathermy coagulation of a vein, but this would only be in the stagnant blood lying in the blind end of the vessel. It seems unlikely that the amount of thrombus forming would be any different from that forming in a vein that has been tied. I think we should readily admit that if diathermy is used in a clumsy fashion-that is to say diathermising much more tissue than is necessary, or proceeding to fulguration with a black eschar-then the amount of local tissue damaged will be greatly increased and there would be an increased risk of small thrombi developing. Certainly with the increasing use of bipolar diathermy coagulation, the chances of fulgurating to a black eschar are much reduced. So I do not think that with careful use of surgical diathermy there is any greater risk of thrombus formation and multiple emboli than there is in a wound in which the vessels have been ligated with absorbable catgut.
